Journal of Pharmaceutical Investigation

  • 제36권4호
  • /
  • Pages.283-286
  • /
  • 2006
  • /
  • 2093-5552(pISSN)
  • /
  • 2093-6214(eISSN)
한국약제학회 (The Korean Society of Pharmaceutical Sciences and Technology)
권호 표지
DOI QR코드

DOI QR Code

Interaction Characteristics of Nucleoside Analogues with Human Organic Anion Transporter 1 and 3

  • 발행 : 2006.08.21
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The present study aimed to investigate the interaction of nucleoside analogs with human organic anion transporter 1 and 3(hOAT1 and hOAT3) that play a primary role in the tubular uptake of endogenous and exogenous organic anions in the kidney. The interactions of ddC, ara-C, ara-A and ara-U with hOAT1 and hOAT3 were examined using MDCK cells stably overexpressing hOAT1 or hOAT3. Among the tested drugs, ddC showed the highest affinity to hOAT1 with $IC_{50}$ values of 5.2 mM, while ara-A, ara-C and ara-U weakly inhibited the cellular uptake of $[^3H]-PAH$ in MDCK-hOAT1 cells at 1 mM. In contrast, all the tested drugs did not have any inhibition effect on the cellular uptake of $[^3H]-estrone$ sulfate in MDCK-hOAT3 cells over the drug concentration of 0.01-2 mM, implying that they might not interact with hOAT3. Taken all together, the present study suggests that hOAT1 could weakly interact with nucleoside analogues such as ddC, ara-C, ara-A and ara-U but the interaction with hOAT3 during the urinary excretion of these nucleoside analogues may be negligible in the kidney.

키워드

참고문헌

  1. B. Angelin, A. Arvidsson, R. Dahlqvist, A. Hedman and K. Schenk-Gustafsson. Quinidine reduces biliary clearance of digoxin in man. Eur. J. Clin. Inves., 17, 262-265 (1987) https://doi.org/10.1111/j.1365-2362.1987.tb01246.x
  2. M. Verschraagen, C.H.W. Koks, J.H.M. Schellens and J.H. Beijnen. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil. Pharmacol. Res., 40, 301-306 (1999) https://doi.org/10.1006/phrs.1999.0535
  3. K. Westphal, A. Weinbrenner, T. Giessmann, M. Stuhr, G. Franke, M. Zschiesche, R. Oertel, B. Terhaag, H.K. Kroemer and W. Siegmund. Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P-glycoprotein. Clin. Pharmacol. Ther., 68, 6-12 (2000) https://doi.org/10.1067/mcp.2000.107579
  4. M.J.M. Hitchcock, H.S. Jaffe, J.C. Martin and RJ. Stagg. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral. Chem. Chemother., 7, 115-127 (1996) https://doi.org/10.1177/095632029600700301
  5. B.C. Burckhardt and G. Burckhardt. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev. Physiol. Biochem. Pharmacol., 146, 95-158 (2003) https://doi.org/10.1007/s10254-002-0003-8
  6. M. Takeda, E. Babu, S. Narikawa and H. Endou. Interaction of human organic anion transporters with various cephalosporin antibiotics. Eur. J. Pharmacol., 438, 137-142 (2002) https://doi.org/10.1016/S0014-2999(02)01306-7
  7. H. Hasannejad, M. Takeda, K. Taki, H.J. Shin, E. Babu, P. Jutabha, S. Khamdang, M. Aleboyeh, M.L. Onozato, A. Tojo, A. Enomoto, N. Anzai, S. Narikawa, X.L. Huang, T. Niwa and H. Endo. Interactions of human organic anion transporters with diuretics. J. Pharmacol. Exp. Ther., 308, 1021-1029 (2004) https://doi.org/10.1124/jpet.103.059139
  8. S. Khamdang, M. Takeda, R. Noshiro, S. Narikawa, A. Enomoto, A. Anzei, P. Piyachaturawat and H. Endou. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther., 303, 534-539 (2002) https://doi.org/10.1124/jpet.102.037580
  9. M. Takeda, S. Khamdang, S. Narikawa, H. Kimura, Y. Kobayashi, T. Yamamoto, S.H. Cha, T. Sekine and H. Endou. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J. Pharmacol. Exp. Ther., 300, 918-924 (2002) https://doi.org/10.1124/jpet.300.3.918
  10. H. Motohashi, Y. Sakurai, H. Saito, S. Masuda, Y. Urakami, M. Goto, A. Fukatsu, O. Ogawa and K. Inui. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J. Am. Soc. Nephrol., 13, 866-874 (2002)
  11. A.G. Aslamkhan, Y.H. Han, X.P. Yang, R.K. Zalups and J.B. Pritchard. Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells. Mol. Pharmacol., 63, 590-596 (2003) https://doi.org/10.1124/mol.63.3.590
  12. J. Crookes, I.H. Stevenson, A.M.M. Shepherd and D.C. Muir. The clinical significance and importance of drug interactions. In Drug Interactions, Grahame-Smith (ed). Macmillan: London, 3-13 (1977)
  13. K.J. Starr and J.C. Petrie. Drug interactions in patients on long-term oral anticoagulant and antihypertensive adrenergic neuron-blocking drugs. BMJ., 4, 133-135 (1972) https://doi.org/10.1136/bmj.4.5833.133
  14. H. Ueo, H. Motohashi, T. Katsura and K. Inui. Human organic anion transporter hOAT3 is a potent transporter of cephalo- sporin antibiotics, in comparison with hOAT1. Biochem. Pharmacol., 70, 1104-13 (2005) https://doi.org/10.1016/j.bcp.2005.06.024
  15. S.H. Cha, T. Sekine, J-I. Fukushima, Y. Kanai, Y. Kobayashi, T. Goya and H. Endou. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol. Pharmacol., 59, 1277-1286 (2001) https://doi.org/10.1124/mol.59.5.1277